HIMS

I was able to buy HIMS around 25 and sold after a quick double. Managed to secure a very nice return.

Now, with the recent controversy involving Novo Nordisk, I expect the price could drop further in the short to mid-term.

Personally, I’ll be scaling in gradually.

My first buy-in is around 36, and the second between 25 and 30, depending on price action.

HIMS is a beautiful company with solid growth figures.

Do you also follow HIMS closely? #hims
$HIMS (+0,31%)
#novonordisk
$NOVO B (-0,14%)